Smartlab Europe

Medrio offers free EDC Software to university researchers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...

It’s Time for the 3rd Generation of Patient Recruitment

Key Takeaways 80% of clinical trials experience enrolment delays and massive...

Driving Documentation Integrity Through Structured Drug Data

Establishing a robust framework for regulatory success requires moving beyond fragmented information silos toward a unified, digital-first approach. Comprehensive oversight of the pharmaceutical lifecycle depends on the ability to transform raw information into actionable insights, ensuring that every data point contributes to a larger narrative of safety and efficacy. By prioritizing specialized platforms that aggregate and organize complex information, organizations can achieve a level of transparency that satisfies the most stringent global standards while fostering a culture of continuous improvement.
- Advertisement -

Medrio, a US-based integrated eClinical software manufacturer, is offering its web-based Electronic Data Capture (EDC) Software for Clinical Research to universities under its Medrio Scholars program.

The firm claims that the EDC software helps researchers to freely initiate studies, which are funded by university and/or government.

With the new EDC software, university researchers can collect and manage clinical trials data, registries, retrospective studies, and patient web surveys.

The software also allows researchers to create and manage their clinical study data collection themselves, without programming.

Medrio CEO Mike Novotny said, “Medrio has been used successfully in Phase I-IV trials, registries, and other clinical studies by 12 of the top 20 global biopharmaceutical companies, and dozens of universities. We are proud to make it available now without charge for academic research.”

With its wide study and data management tools, the company claims that the software will fully validate and meet the requirements for electronic records and signatures (21 CFR Part 11), Health Insurance Portability and Accountability Act (HIPAA) and the European and Swiss Safe harbor frameworks.

Latest stories

Related stories

Roche AI Factory Expansion to Boost Pharma R&D Capacity

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure...

It’s Time for the 3rd Generation of Patient Recruitment

Key Takeaways 80% of clinical trials experience enrolment delays and massive...

Driving Documentation Integrity Through Structured Drug Data

Establishing a robust framework for regulatory success requires moving beyond fragmented information silos toward a unified, digital-first approach. Comprehensive oversight of the pharmaceutical lifecycle depends on the ability to transform raw information into actionable insights, ensuring that every data point contributes to a larger narrative of safety and efficacy. By prioritizing specialized platforms that aggregate and organize complex information, organizations can achieve a level of transparency that satisfies the most stringent global standards while fostering a culture of continuous improvement.

Contamination Control with Toxicological Reference Data

Centralizing expert-verified toxicological datasets is now a critical requirement for modern pharmaceutical facilities operating under stringent global regulations. By transitioning from generic cleaning limits to precise Health-Based Exposure Limits derived from high-quality platforms, manufacturers ensure that cleaning validation protocols are scientifically sound and audit-ready. This approach integrates rigorous toxicological risk assessment into the broader contamination control strategy, safeguarding patient health while optimizing multi-product manufacturing efficiency and regulatory compliance.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »